InspireMD Announces CE Mark Approval for CGuard\u00ae Prime Embolic Prevention System (EPS) Under European MDR for the Preventio

• click to rate

  Posted by Two Blokes Jun 13 - Filed in Stock - 6 views
  
  MIAMI, June 13, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard\u00ae Prime carotid stent system for the prevention of stroke, today announced the company has received CE Mark approval under the European Medical Device Regulation (MDR) for the CGuard\u00ae Prime EPS.